BP reduction by SGLT2 inhibitors is associated with a reduction in the arterial stiffness, as demonstrated by the pulse wave velocity and augmentation index in patients with T1D [49]. This evidence concerns the gene SLC5A2 and type 1 diabetes mellitus.